Back to Search Start Over

A QM/MM study of the molecular recognition site of bapineuzumab toward the amyloid-β peptide isoforms

Authors :
Exequiel Ernesto Barrera Guisasola
Nelida Maria Peruchena
Ricardo D. Enriz
Lucas J. Gutierrez
Source :
Molecular Simulation. 42:196-207
Publication Year :
2015
Publisher :
Informa UK Limited, 2015.

Abstract

The molecular mechanism of recognition of amyloid-beta (Aβ) peptide isoforms by bapineuzumab was studied using a quantum mechanics and molecular mechanics (QM/MM) method. In this work, geometric optimisations were performed using the ONIOM2 scheme (at B3LYP/6-31G(d) amber)EE level) on the paratope of bapineuzumab together with the different forms of Aβ peptide (AβWT and AβN3(pE)). A comprehensive study of the interactions was also performed through Quantum Theory of Atoms in Molecules (QTAIM). This allowed us to obtain a deep understanding of how this antibody interacts with the amino acids of the Aβ peptides. The description on the interactions between bapineuzumab and the different forms of Aβ peptides allow us to understand why the peptides that lack the two first residues (Asp1 and Ala2) and begin with a pyroglutamate residue present low affinity for bapineuzumab. This basic structural information is useful for a deeper understanding about the scope and limitations of bapineuzumab as a therapeutic agent for the AD. Fil: Gutierrez, Lucas Joel. Universidad Nacional del Nordeste; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Barrera Guisasola, Exequiel Ernesto. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de San Luis; Argentina Fil: Peruchena, Nelida Maria. Universidad Nacional del Nordeste; Argentina Fil: Enriz, Ricardo Daniel. Universidad Nacional de San Luis; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina

Details

ISSN :
10290435 and 08927022
Volume :
42
Database :
OpenAIRE
Journal :
Molecular Simulation
Accession number :
edsair.doi.dedup.....2330850771b8daf643af739debe969a9